Efficacy and safety outcomes of darolutamide in patients with nonmetastatic castration-resistant prostate cancer with comorbidities and concomitant medications from ARAMIS

Egils Vjaters; Karim Fizazi; Shore Neal D.; Neal ShoreMatthew Raymond Smith[...]Frank Verholen; Smith Matthew Raymond; Verholen; Ramos Rodrigo; Neal ShoreMatthew Raymond Smith[...]Frank; Jones Robert J.; Niegisch Guenter

Efficacy and safety outcomes of darolutamide in patients with nonmetastatic castration-resistant prostate cancer with comorbidities and concomitant medications from ARAMIS

Egils Vjaters
, Karim Fizazi
, Shore Neal D.
, Neal ShoreMatthew Raymond Smith[...]Frank Verholen
, Smith Matthew Raymond
, Verholen
, Ramos Rodrigo
, Neal ShoreMatthew Raymond Smith[...]Frank
, Jones Robert J.
, Niegisch Guenter

Ne LU

Research output: Contribution to journal › Meeting abstract › peer-review

Original language	English
Journal	Journal of Clinical Oncology
Volume	40
Issue number	6
Publication status	Published - 2022

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

OECD Field of Science

3. Medical and Health Sciences

Cite this

Vjaters, E., Fizazi, K., Neal D., S., ShoreMatthew Raymond Smith[...]Frank Verholen, N., Matthew Raymond, S., Verholen, Rodrigo, R., Neal ShoreMatthew Raymond Smith[...]Frank, Robert J., J., & Guenter, N. (2022). Efficacy and safety outcomes of darolutamide in patients with nonmetastatic castration-resistant prostate cancer with comorbidities and concomitant medications from ARAMIS. Journal of Clinical Oncology, 40(6).

@article{1b1768f4a45a4880bf5f599d3ab963e1,

title = "Efficacy and safety outcomes of darolutamide in patients with nonmetastatic castration-resistant prostate cancer with comorbidities and concomitant medications from ARAMIS",

author = "Egils Vjaters and Karim Fizazi and \{Neal D.\}, Shore and \{ShoreMatthew Raymond Smith[...]Frank Verholen\}, Neal and \{Matthew Raymond\}, Smith and Verholen and Ramos Rodrigo and \{Neal ShoreMatthew Raymond Smith[...]Frank\} and \{Robert J.\}, Jones and Niegisch Guenter",

year = "2022",

language = "English",

volume = "40",

journal = "Journal of Clinical Oncology",

issn = "0732-183X",

publisher = "Lippincott Williams and Wilkins",

number = "6",

}

Vjaters, E, Fizazi, K, Neal D., S, ShoreMatthew Raymond Smith[...]Frank Verholen, N, Matthew Raymond, S, Verholen, Rodrigo, R, Neal ShoreMatthew Raymond Smith[...]Frank, Robert J., J & Guenter, N 2022, 'Efficacy and safety outcomes of darolutamide in patients with nonmetastatic castration-resistant prostate cancer with comorbidities and concomitant medications from ARAMIS', Journal of Clinical Oncology, vol. 40, no. 6.

TY - JOUR

T1 - Efficacy and safety outcomes of darolutamide in patients with nonmetastatic castration-resistant prostate cancer with comorbidities and concomitant medications from ARAMIS

AU - Vjaters, Egils

AU - Fizazi, Karim

AU - Neal D., Shore

AU - ShoreMatthew Raymond Smith[...]Frank Verholen, Neal

AU - Matthew Raymond, Smith

AU - Verholen, null

AU - Rodrigo, Ramos

AU - Neal ShoreMatthew Raymond Smith[...]Frank, null

AU - Robert J., Jones

AU - Guenter, Niegisch

PY - 2022

Y1 - 2022

M3 - Meeting abstract

SN - 0732-183X

VL - 40

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

IS - 6

ER -